Kaitlin Kestenberg serves as the Chief Operating Officer and Senior Vice President of Compliance at ADMA Biologics Inc., a role that underscores her extensive experience and leadership in the biopharmaceutical industry. With a robust background in operations and regulatory compliance, Kestenberg has been instrumental in steering ADMA Biologics towards achieving its strategic goals. Prior to joining ADMA Biologics, she held various high-level positions at other notable biopharmaceutical companies, where she honed her skills in managing complex operations and ensuring adherence to stringent regulatory standards. In her current role at ADMA Biologics, Kestenberg oversees the company's day-to-day operations, ensuring that all processes align with the highest standards of compliance and efficiency. Her leadership has been pivotal in the successful launch and expansion of ADMA's product portfolio, particularly in the areas of immunoglobulin therapies. Kestenberg's strategic vision and commitment to excellence have not only enhanced the company's operational capabilities but also solidified its reputation as a leader in the biopharmaceutical sector. Her contributions have been vital in navigating the challenges of the industry, from regulatory hurdles to market competition, thereby driving sustained growth and innovation at ADMA Biologics.